These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33417509)

  • 1. Second generation drug-eluting stents: a focus on safety and efficacy of current devices.
    Spione F; Brugaletta S
    Expert Rev Cardiovasc Ther; 2021 Feb; 19(2):107-127. PubMed ID: 33417509
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents.
    El-Hayek G; Bangalore S; Casso Dominguez A; Devireddy C; Jaber W; Kumar G; Mavromatis K; Tamis-Holland J; Samady H
    JACC Cardiovasc Interv; 2017 Mar; 10(5):462-473. PubMed ID: 28279314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From biodegradable polymers to bioresorbable vascular scaffolds: available evidence in the era of new-generation drug-eluting stents.
    Magliulo F; Piccolo R; Franzone A; Esposito G; Danzi GB
    Minerva Cardioangiol; 2018 Jun; 66(3):246-261. PubMed ID: 29160048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
    Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T
    Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-Year Outcomes of Biodegradable Polymer Drug-Eluting Stents Versus Second-Generation Durable Polymer Drug-Eluting Stents: a Meta-Analysis of Randomized Controlled Trials.
    Lou Y; Yu Y; Xi Z; Gao Y; Liu W; Nie X
    Cardiovasc Drugs Ther; 2019 Oct; 33(5):557-566. PubMed ID: 31773343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the MiStent sustained sirolimus eluting biodegradable polymer coated stent for the treatment of coronary artery disease: does uniform sustained abluminal drug release result in earlier strut coverage and better safety profile?
    Tijssen RYG; Kraak RP; Lu H; Mifek JG; Carlyle WC; Donohoe DJ; De Winter RJ; Koch KT; Wykrzykowska JJ
    Expert Rev Med Devices; 2017 May; 14(5):325-334. PubMed ID: 28402204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.
    Raungaard B; Christiansen EH; Bøtker HE; Hansen HS; Ravkilde J; Thuesen L; Aarøe J; Villadsen AB; Terkelsen CJ; Krusell LR; Maeng M; Kristensen SD; Veien KT; Hansen KN; Junker A; Madsen M; Andersen SL; Jensen SE; Jensen LO;
    JACC Cardiovasc Interv; 2017 Feb; 10(3):255-264. PubMed ID: 28109874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives.
    Iglesias JF; Roffi M; Degrauwe S; Secco GG; Aminian A; Windecker S; Pilgrim T
    Expert Rev Med Devices; 2017 Oct; 14(10):773-788. PubMed ID: 28889769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A propensity score-matched comparison of biodegradable polymer vs second-generation durable polymer drug-eluting stents in a real-world population.
    Zhao YJ; Teng M; Khoo AL; Ananthakrishna R; Yeo TC; Lim BP; Loh JP; Chan MY
    Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29316284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials.
    Zhu P; Zhou X; Zhang C; Li H; Zhang Z; Song Z
    BMC Cardiovasc Disord; 2018 Aug; 18(1):170. PubMed ID: 30111289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stent Polymers: Do They Make a Difference?
    Rizas KD; Mehilli J
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27193905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term patient benefit with biodegradable polymer biolimus eluting stent.
    Corti R
    Minerva Cardioangiol; 2012 Dec; 60(6):629-36. PubMed ID: 23147439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of biodegradable polymer versus durable polymer drug-eluting stents incorporating real-world evidence.
    Teng M; Zhao YJ; Khoo AL; Ananthakrishna R; Yeo TC; Lim BP; Chan MY; Loh JP
    Cardiovasc Ther; 2018 Oct; 36(5):e12442. PubMed ID: 29873191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the Orsiro Hybrid drug-eluting stent in high-risk subgroups.
    Iglesias JF; Muller O; Zuffi A; Eeckhout E
    Minerva Cardioangiol; 2016 Feb; 64(1):55-73. PubMed ID: 26542119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes of Biodegradable Versus Second-Generation Durable Polymer Drug-Eluting Stent Implantations for Myocardial Infarction.
    Choe JC; Cha KS; Lee JG; Kim J; Shin JY; Ahn J; Park JS; Lee HW; Oh JH; Choi JH; Lee HC; Hong TJ; Jeong MH;
    JACC Cardiovasc Interv; 2020 Jan; 13(1):97-111. PubMed ID: 31918948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of late-acquired stent malapposition of drug eluting stents with second generation permanent and biodegradable polymer coatings-A prospective, randomized comparison using optical coherence tomography.
    Roth C; Gangl C; Dalos D; Delle-Karth G; Neunteufl T; Berger R
    J Interv Cardiol; 2018 Dec; 31(6):780-791. PubMed ID: 30479028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel bioabsorbable polymer and polymer-free metallic drug-eluting stents.
    Nogic J; McCormick LM; Francis R; Nerlekar N; Jaworski C; West NEJ; Brown AJ
    J Cardiol; 2018 May; 71(5):435-443. PubMed ID: 29338896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.
    Buiten RA; Ploumen EH; Zocca P; Doggen CJM; Danse PW; Schotborgh CE; Scholte M; van Houwelingen KG; Stoel MG; Hartmann M; Tjon Joe Gin RM; Somi S; Linssen GCM; Kok MM; von Birgelen C
    JACC Cardiovasc Interv; 2019 Sep; 12(17):1650-1660. PubMed ID: 31422087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-Generation Coronary Stents: Current Data and Future Directions.
    Kalra A; Rehman H; Khera S; Thyagarajan B; Bhatt DL; Kleiman NS; Yeh RW
    Curr Atheroscler Rep; 2017 Mar; 19(3):14. PubMed ID: 28220461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.